For ccRCC it was shown that numerous cases of downregulated expression of VHL tumor suppressor, inactivated in approx. 50% of ccRCC patients, result from hypermethylation of the gene’s promoter [16]. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.